Lv6
1800 积分 2021-10-08 加入
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study
2天前
已完结
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
2天前
已完结
A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia
10天前
已完结
Plasminogen supplementation reverses fibrinolytic insufficiency in sepsis-induced disseminated intravascular coagulation: a pilot study
23天前
已完结
Airway management of adults in the acute care setting
24天前
已关闭
Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
26天前
已完结
Selective Decontamination of the Digestive Tract during Ventilation in the ICU
26天前
已完结
The Age Illusion — Limitations of Chronologic Age in Medicine
1个月前
已完结
Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
1个月前
已完结
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
